News

SWOG Front Line banner
The Front Line
Feb 28, 2025

Documenting Impact and Vision: NCTN Grants Submitted

SWOG Front Line banner
The Front Line
Feb 21, 2025

Pitching the PAC for Maximum ImPACt

We can declare Pitch the PAC an unqualified success
US Capitol building
Announcement
Feb 21, 2025

A Message from the NCTN Group Chairs

The Importance of Research Funding
SWOG Front Line banner
The Front Line
Feb 14, 2025

Nothing but Blue Skies Do I See (Thinking about Social Media)

Bluesky is reminiscent of #MedTwitter's early years – excitement, community, even fun
SWOG Front Line banner
The Front Line
Feb 7, 2025

Spring Group Meeting: Shorter, But Sweeter

SWOG Front Line banner
The Front Line
Jan 31, 2025

Results of S1613: HER2 Inhibitors for HER2+ CRC

Primary results from S1613 in colorectal cancer are now in JCO
S1613 in JCO
Press Release
Jan 29, 2025

S1613: In HER2+ CRC, Anti-HER2 Therapy May Be Less Toxic Alternative

When CRC is HER2+, dual HER2 inhibitor may beat standard EGFR inhibitors
Development and validation of the RSClinN+ tool
Press Release
Jan 24, 2025

RSClin® Tool N+: more accurate estimates of recurrence risk, chemo benefit in node+ breast cancer

SWOG Front Line banner
The Front Line
Jan 24, 2025

Member Highlight: Lahey Hospital & Medical Center